ERBB2 and breast cancer: The most aggressive, invasive and with poor prognosis type of breast cancer is the triple negative breast cancer (TNBC), which is immunohistochemically characterized by the lack of estrogen receptor, progesterone receptor and absence of HER2 amplification [1].